Acelyrin, Inc. (SLRN) Financials
Stock symbol SLRN is outdated, potentially delisted? Maybe it is available on other exchange?
SLRN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 800.5 million | 1.2 billion |
| June 30, 2023 | 835.1 million | 34.1 million |
| March 31, 2023 | 298.5 million | 298.5 million |
| Dec. 31, 2022 | 333.0 million | 444.4 million |
SLRN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -39.3 million | 15.3 million |
| June 30, 2023 | -33.4 million | 8.5 million |
| March 31, 2023 | -35.6 million | 7.1 million |
| Dec. 31, 2022 | -18.1 million | 1.5 million |
SLRN Net Income
No data available :(
SLRN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 788.4 million | - | 1.3 million |
| June 30, 2023 | 823.0 million | - | 1.3 million |
| March 31, 2023 | 289.2 million | - | 1.3 million |
| Dec. 31, 2022 | 326.1 million | - | - |
SLRN Shares Outstanding
SLRN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | 197000 | 74.6 million | 19.9 million | - |
| June 30, 2023 | 1.8 million | 30.0 million | 12.7 million | - |
| March 31, 2023 | 10.2 million | 167.9 million | 11.9 million | - |
| Dec. 31, 2022 | - | 192.4 million | 15.9 million | - |
SLRN Cost of Revenue
No data available :(
SLRN
Price: $2.27
52 week price:
Earnings Per Share: -2.69 USD
P/E Ratio: -0.84
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Market Capitalization: 229.2 million